DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $21,252 | +3.4% | 85,657 | 0.0% | 2.76% | +4.2% |
Q2 2023 | $20,558 | -4.8% | 85,657 | 0.0% | 2.64% | -12.6% |
Q1 2023 | $21,589 | -3.6% | 85,657 | +1.5% | 3.03% | -9.8% |
Q4 2022 | $22,400 | -99.9% | 84,394 | +1.9% | 3.36% | -1.2% |
Q3 2022 | $21,401,000 | -2.2% | 82,858 | -4.0% | 3.40% | +9.1% |
Q2 2022 | $21,874,000 | -13.1% | 86,281 | +0.5% | 3.12% | +4.6% |
Q1 2022 | $25,180,000 | -7.7% | 85,843 | +3.6% | 2.98% | -4.8% |
Q4 2021 | $27,273,000 | +7.9% | 82,893 | -0.1% | 3.13% | -3.1% |
Q3 2021 | $25,273,000 | +12.8% | 83,015 | -0.6% | 3.23% | +3.2% |
Q2 2021 | $22,408,000 | +53.9% | 83,501 | +29.1% | 3.13% | +16.8% |
Q1 2021 | $14,557,000 | +5.3% | 64,676 | +3.9% | 2.68% | -2.9% |
Q4 2020 | $13,822,000 | – | 62,221 | – | 2.76% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |